NHS Scotland Chooses Carestream Technology for Breast Cancer Screening

CarestreamNHS Scotland has further strengthened its strategic partnership with Carestream Health by signing an amendment to the long standing contract between the two organisations. The company will supply CARESTREAM Vue Mammography PACS to all of Scotland's Breast Screening Centres located at Edinburgh, Glasgow, Aberdeen, Inverness, Dundee and Irvine. These centres provide breast cancer screening to more than 175,000 women each year.

The new agreement builds on the success of Carestream's Vue PACS System installed in all NHS hospitals in Scotland that has improved access to radiology images and patient information across the country's highly rated healthcare system.

The agreement also includes Vue Mammography PACS for the fleet of mobile breast screening units run by NHS Scotland as well as the Pathology and Medical Physics departments at each site. Carestream will install its system during 2013 and early 2014, commencing with Edinburgh and Glasgow which are the two largest sites.

"Currently all our breast screening centres are either completely film based or have digital modalities with no universal method of viewing, reporting and distributing images," said Liz Blackman, Senior Programme Manager, NHS National Services Scotland. "Carestream Mammography PACS will solve this issue as images will be immediately available for review and reporting and our clinicians can have immediate access to specialist advice across Scotland regardless of where the screening was carried out."

The new system from Carestream will provide convenient access and synchronisation of all patient information, procedures and status across Scotland’s entire breast screening network to streamline reading workflow and accelerate the delivery of screening results.

"This latest development for Mammography PACS across all Breast Screening Centres in Scotland will transform the Breast Screening Service from a film based system into a digital enterprise that will improve the speed and access to screening images, information and results," said Charlie McCaffrey, Managing Director, Carestream in the UK. "The success of CARESTREAM PACS across the country has streamlined care and enabled faster diagnosis and treatment for patients. This next step to include the Breast Screening Service is a logical progression and further deepens and strengthens the strategic relationship between NHS Scotland and Carestream."

Related news articles:

About Carestream Health
Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...